Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"No discrete molecular binding target" is a pharmacological classification used to describe therapeutic agents that exert their effects through physical or chemical means rather than by binding to a specific biological macromolecule like a receptor, enzyme, or ion channel (DrugBank Online, 2024). This category encompasses a diverse range of substances, including antacids that neutralize gastric acid via simple chemical reactions and osmotic laxatives that alter fluid balance through physical gradients (StatPearls, 2023). Because these agents do not rely on the traditional "lock-and-key" mechanism of drug-receptor interaction, their efficacy is typically determined by their concentration and physical properties within a specific physiological compartment (Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13th Ed). Common examples include activated charcoal, which adsorbs toxins in the gut, and bulk-forming fibers that physically increase stool volume (PubChem, 2024). While these agents are therapeutically active, they lack the high specificity associated with molecularly targeted therapies, often leading to broad physiological effects such as electrolyte shifts or changes in the absorption of co-administered drugs (NIH, 2023). This classification is essential for categorizing drugs whose therapeutic utility is derived from their intrinsic chemical reactivity or physical presence rather than affinity for a protein binding site.
Physical or chemical interaction (e.g., osmosis, neutralization, adsorption) without specific protein binding.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No discrete molecular binding target.